Marijuana Arrests Soar in Allentown and Bethlehem as Both Cities Consider Marijuana Decriminalization

Police in the Pennsylvania cities of Allentown and Bethlehem continue to arrest hundreds of residents for less than 30 grams of cannabis while opiate and cocaine arrests seem to be going down.

Last year Allentown put 315 people into handcuffs and the courts over marijuana possession, while the city reported just 31 other drug possession arrests during 2017, according to data from the Pa. Uniform Crime Reporting System.

Bethlehem police also favor arresting cannabis consumers, between 130 and 160 per year are caught up in the criminal justice system over a few joints. Data from Bethlehem is also showing some odd trends, with zero opiate or cocaine arrests logged in 2016 or 2017.

“Decriminalization would seem a simple and effective option anywhere,” said Lehigh Valley NORML Director Jeff Riedy, “When you consider the human cost to those convicted of arrests for possession of small amounts of marijuana.”

A RAND Corp. study commissioned for Vermont found that each marijuana arrest is estimated to cost taxpayers $ 1,266 to perform. Prosecuting each person spends another $ 1,000 according to some estimates.

That means Allentown and Bethlehem spent over $ 1 million last year treating otherwise law abiding cannabis consumers like criminals. Thankfully the city councils in both communities have introduced ordinances to address this expensive injustice.

“The decrim ordinances, like that in Philadelphia, have helped to remove stigma, freed up the courts and allowed law enforcement to focus on more pressing issues. We should stop ruining lives over a joint,” said Riedy.

Lehigh Valley NORML encourages members of the press and elected officials to review the marijuana possession arrest data included with this release.

According to Pa. State Representative Michael Schlossberg (D., Lehigh), cosponsor of two statewide decriminalization bills in Harrisburg, “It’s time to put an end to senseless mass incarceration brought on by the prohibition of marijuana. I have added my name to legislation to decriminalize possession of marijuana and bring commonsense back to our criminal justice system.  Pennsylvanian’s cannot afford to continue to follow the path of failed policies which hurt individuals and communities.”

Allentown introduced their ordinance at Council last week, and it has been moved to a Committee of the Whole, scheduled for Tuesday, May 8 at 6pm in Council Chambers. If it passes the Committee with a majority vote, the ordinance will move to the full City Council for a vote next Wednesday, May 16 at 7pm. Public opinion is encouraged both dates.

Allentown’s proposed ordinance: http://allentownpa.legistar.com/View.ashx?M=F&ID=6212844&GUID=F77277E0-5440-436B-B430-9CAC4AFFB0BD

For more info, please contact Jeff Riedy at 610-533-0906 or via email at lehighvnorml@gmail.com. You can also follow Lehigh Valley NORML on FaceBook and Twitter!

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , , , , | Leave a comment

Missouri Medical Marijuana Initiative Filed

Dear Friends,

On Friday, May 4, 2018, the New Approach Missouri medical marijuana initiative campaign filed more than 372,400 signatures with the Office of the Missouri Secretary of State in Jefferson City.  Only 168,000 valid signatures are required in order to place the legalization of medical access to cannabis for therapeutic purposes on the ballot in Missouri in November of 2018.

Fieldworks, the professional petitioning company retained by NAM did an excellent job of gathering signatures and keeping the campaign’s Board of Directors informed, on a daily basis, of the number of signatures gathered in each county and each congressional district in our state.  We are virtually certain to have well in excess of the required signatures to be certified for the November ballot.

This accomplishment is the result of the generosity of hundreds of donors and the work of hundreds of volunteers who gathered signatures for this initiative.  I thank all of you who have contributed generously to support this effort.  I ask you to consider making a donation at this time to support the campaign to pass this measure by going to NewApproachMissouri.org.

All polling has indicated that support for medical marijuana in Missouri is well above 60%.  Only 50% of voters is required in order for this initiative to succeed in amending our state’s Constitution.  Although one or possibly two other medical marijuana initiatives may be placed on the ballot, ours will be first among the Constitutional amendments on this topic.  If both of the two Constitutional amendment initiatives pass, the one with more votes will prevail.

The other two medical marijuana initiatives being circulated do not allow for any patient cultivation.  The other Constitutional amendment initiative would impose the highest tax on medical marijuana in the country.  That tax would go to support a medical research institute which will be required to be headed by one who is both a lawyer and a doctor.  The individual who filed this initiative happens to hold both a J.D. and an M.D. degree.  Further, that research institute’s board of directors will be hand-picked by the individual who filed the initiative, the same individual who will apparently be heading that research institute, which would be funded by imposing a high tax on medical marijuana patients, who would have no legal alternative to purchasing cannabis from dispensaries through this very restrictive proposal.

The other initiative proposes to enact a statutory law.  If either of the Constitutional amendments passes, this statutory initiative will be rendered irrelevant.  Further, the Missouri General Assembly has demonstrated that it will not hesitate to repeal or radically amend any statutory initiative passed by the voters.

Please contact me with any questions or concerns.

Sincerely,

Dan Viets, Chair

New Approach Missouri

Board of Directors

For more info, please contact Dan Viets via email at danviets@gmail.com. You can also follow New Approach Missouri on FaceBook and Twitter!

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , | Leave a comment

Hemp brings jobs and more than $16.7 million in sales to Kentucky

Beth Warren, Louisville Courier Journal Published 11:57 a.m. ET May 1, 2018

A report card of sorts grading hemp’s impact on Kentucky showed these scores:

Eighty-one new full-time jobs. More than $16.7 million in gross product sales. And $7.5 million for farmers.

Kentucky Agriculture Commissioner Ryan Quarles included these figures from last year in an April 24 letter to U.S. Senate Majority Leader Mitch McConnell and Sen. Rand Paul calling hemp’s economic impact “significant.”

“My goal is to make Kentucky an epicenter for hemp farmers and processors,” Quarles wrote, according to a copy of the letter obtained this week by Courier Journal.

He said he wants Kentucky to “have a head start in the race against competitors in other states,” as he anticipates Congress will remove the crop from the list of federally controlled substances. McConnell is pushing for this legislative change to remove a barrier inhibiting the versatile plant some call marijuana’s kissing cousin. This would clear up confusion about whether its products are or aren’t legal.

The push to legalize: Mitch McConnell is fighting hard to legalize hemp

More info: Are you breaking the law when you buy hemp products?

Police have fought the legalization of hemp since 2012, complaining that they can’t easily decipher hemp from marijuana, said Tommy Loving, head of the Kentucky Narcotics Officers’ Association.

McConnell was key to the federal “2014 Farm Bill” that gave states the power to allow industrial hemp and to test the market to see if consumers would buy its products — which range from “superfood” seeds to clothing and cannabidiol or CBD oils used to treat headaches. The Delta-9 tetrahydrocannabinol — a psychoactive compound better known as THC — was limited to 0.3, a negligible amount that won’t allow for a buzz.

In Kentucky, hemp can only be grown with the approval of state agriculture officials while it remains a controlled substance. Quarles said other states have called for help modeling their program after the one Kentucky uses.

Reporter Beth Warren: bwarren@courier-journal.com; 502-582-7164; Twitter @BethWarrenCJ. Support strong local journalism by subscribing today: www.courier-journal.com/bethw.

Hemp vs pot: Can you get high off hemp? More info on marijuana’s ‘kissing cousin’

Hemp instead of opioids?: Hemp is ‘the next big thing’ in pain management as growth and research expand in Kentucky

CONTINUE READING…

Categories: US Hemp Co Museum | Leave a comment

Weekly Legislative Roundup 5/4/18

Welcome to the latest edition of NORML’s Weekly Legislative Roundup!

Let’s talk about some new state-level developments. The Maine House of Representatives and Senate overrode Gov. Paul LePage’s (R) veto of marijuana legalization implementation legislation this week. The enactment of the legislation establishes a framework for the retail sale of marijuana to adults, but also amends numerous provisions of the 2016 voter-approved measure — including those specific to home grow limits and taxation.

The New Approach Missouri medical cannabis campaign submitted 372,483 petition signatures to put their language first on this November’s ballot.

Also at the state level, the Alaska legislature approved a resolution urging the federal government to respect the state’s marijuana laws, the Arizona House of Representatives defeated a bill to require medical cannabis testing, and The New Hampshire Senate voted 14-10 to hold a medical cannabis homegrow bill for interim study, effectively killing it for the year.

At a more local level, Seattle, Washington’s mayor and city attorney are asking a court to vacate convictions and dismiss charges for marijuana possession. And the Philadelphia, Pennsylvania City Council approved a resolution calling on Congress to pass the Marijuana Justice Act.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Your Highness,
Carly

Priority Alerts

Federal

End Prohibition: Representatives Tom Garrett (R-VA) and Tulsi Gabbard (D-HI) have introduced bipartisan legislation, HR 1227, to exclude marijuana from the Controlled Substances Act, thus leaving states the authority to regulate the plant how best they see fit.

The “Ending Federal Marijuana Prohibition Act of 2017” eliminates federal criminal penalties for possessing and growing the plant. This legislation gives states the power and flexibility to establish their own marijuana policies free from federal interference.

Click here to e-mail your Representative and urge them to support this important legislation

New Hampshire

SB 388 would expand the state’s medical cannabis program.

The bill would authorize the Department of Health and Human Services to establish a second dispensary location in the geographic area that includes Carroll, Coos, and Grafton counties for therapeutic cannabis.

Update: Members of the House passed SB 388 on a voice vote on 4/28. Governor Chris Sununu’s spokesman Ben Vihstadt said that the governor plans to sign SB 388 into law.

NH resident? Click here to email Gov. Sununu in support of medical expansion

Louisiana

House Bill 579 would expand the state’s nascent medical cannabis program.

The measure would expand the pool of patients eligible for medical cannabis by permitting physicians to authorize cannabis therapy to those suffering from chronic pain, post traumatic stress disorder, severe muscle spasms or glaucoma. The bill was already approved by the House last month.

Update: The Senate Health & Welfare Committee voted 4-2 to approve HB 579 on 5/2 with amendments. The committee amendments were adopted on 5/3.

LA resident? Click here to email your elected officials in support of medical expansion

California

Assembly Bill 1793, would “allow automatic expungement or reduction of a prior cannabis conviction for an act that is not a crime as of January 1, 2017, or for a crime that as of that date subject to a lesser sentence.

Update: The Assembly’s Appropriations Committee held a hearing on AB 1793 on 5/2, but no action was taken on the bill.

CA resident? Click here to email your elected officials in support of automatic expungement

Delaware

Medical
House Bill 374 would expand the state’s medical cannabis access program.

The measure would expand the pool of patients eligible for medical cannabis by permitting physicians to authorize cannabis therapy to those suffering from: chronic debilitating migraines, pediatric autism spectrum disorder, and pediatric sensory processing disorder.

Update: HB 374 passed the House on 5/1, and now awaits action in the Senate Health, Children & Social Services Committee.

DE resident? Click here to email your elected officials in support of medical expansion

Expungement
SB 197 was just introduced, to permit those convicted of past marijuana possession convictions to seek expungement.

The measure would allow individuals to file a petition with the court requesting the expungement of any past marijuana possession violations that are no longer defined as a crime under state law. State officials estimate the legislation could affect up to 1,250 people convicted of a single marijuana crime from 1977 to 2015.

DE resident? Click here to email your elected officials in support of expungement

Illinois

House Bill 2367 provides for the automatic expungement of past marijuana possession or paraphernalia violations.

The measure mandates the automatic expungement of any citation for a civil law violation of either: subsection (a) of Section 4 of the Cannabis Control Act, or subsection (c) Section 3.5 of the Drug Paraphernalia Control Act.

Update: HB 2367 was amended on the House floor on 4/27, then re-referred to the Rules Committee.

IL resident? Click here to email your elected officials in support of automatic expungement

Hawaii

House Bill 2729 would allow for out-of-state medical marijuana cardholders to access medical cannabis while visiting Hawaii.

Other provisions in the bill prohibit employers from either discriminating against or taking punitive actions against employees solely based on their medical cannabis use or patient status. A Conference Committee was appointed last month to reconcile disagreement between the House and Senate on proposed amendments.

Update: The Conference Committee recommended the measure be passed on 4/27, and both the House and Senate agreed to pass HB 2729 with amendments on 5/1. The bill now awaits action from Governor Ige.

HI resident? Click here to email Gov. Ige in support of reciprocity

 

Additional Actions to Take

California

Senate Bill 1302 would prohibit local governments from banning home deliveries from state-licensed cannabis providers into their jurisdictions.

Update: SB 1302 was heard by the Senate Governance & Finance Committee on 5/2, and then approved by the committee. It’s expected to soon be considered by the full House.

CA resident? Click here to email your elected officials in support of cannabis home deliveries

Iowa

Senate File 2372 seeks to expand the state’s medical cannabidiol (CBD) law by removing the arbitrary 3 percent cap on THC content, and would allow doctors to recommend CBD to those suffering from chronic pain as well as to any other patient for whom they believe it would benefit. The bill was recently approved by the Senate Ways and Means Committee, but was never assigned to another committee.

Update: Similar legislation, SF 2405, is facing strong opposition by House Speaker Linda Upmeyer, stating that she wants to wait to hear recommendations from a state advisory board set up under last year’s legislation. Gov. Kim Reynolds agrees with her.

IA resident? Click here to email your elected officials in support of CBD expansion

Missouri

Senate Bill 547 and House Bill 2034would allow the Department of Agriculture to issue a registration or permit to growers and handlers of agricultural and industrial hemp. It would also create an industrial hemp agricultural pilot program to be implemented by the Department of Agriculture to study the growth, cultivation, and marketing of industrial hemp.

Update: HB 2034 passed the House 133-6 5/3. The Senate passed the bill 29-3 5/2. It now awaits action from Governor Eric Greitens.

MO resident? Click here to email Gov. Greitens in support of industrial hemp

Illinois

Senate Bill 2298 provides for the ability for individuals to cultivate hemp with a state license even if they are not part of the state’s Agriculture Department pilot program. That program only permits hemp cultivation as part of a state-sponsored research program. The bill was already passed by the Senate last week.

Update: SB 2298 will be heard by the House Agriculture & Conservation Committee at 2pm on 5/8/18 in Room 413 Stratton Building.

IL resident? Click here to email your elected officials in support of industrial hemp expansion

That’s all for this week, check back next Friday for more legislative updates!

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , | Leave a comment

Ninth Circuit Court Rejects Challenge To DEA’s Classification Of Marijuana Extracts

A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. The DEA first announced the proposed rule change in 2011, but did not enact the new policy until January 13, 2017.

In a decision filed on April 30, the Court rejected petitioners’ arguments – opining the DEA’s classification of marijuana extracts does not conflict with the provisions of either the Agricultural Act of 2014 (aka the ‘Farm Bill) or the Consolidated Appropriations Act, which limits the Justice Department from spending federal dollars to intervene in state-sanctioned activities involving marijuana or industrial hemp. The Court also dismissed petitioners’ argument that the rule substantively amended the federal Controlled Substances Act. Justices opined that such extract products, including those containing primarily CBD, were already classified under federal law as schedule I controlled substances.

The DEA has long contended that it possesses broad regulatory authority over “all parts of the plant Cannabis sativa L.,” including “the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin.” The agency includes among this definition products containing cannabidiol or any other non-THC cannabinoids derived from the marijuana plant. It further states, “[T]he Agricultural Act of 2014 does not permit entities [who are not registered with the DEA] … to produce non-FDA-approved drug products made from cannabis.”

Over a dozen states have enacted legislation in recent years exempting certain persons who possess extracts high in cannabinoid from criminal prosecution. Legislation to approve the retail sale of CBD extracts to adults in Kansas is awaiting gubernatorial action. Indiana lawmakers approved a similar law in April. Several pieces of legislation seeking to exclude CBD from the federal definition of marijuana are pending in Congress. In 2015, Nora Volkow, the Director of the US National Institute on Drug Abuse, publicly acknowledged that CBD is “a safe drug with no addictive effects.”

Petitioners say that they intend to appeal the ruling.

The case is Hemp Industries Association et al., v. US Drug Enforcement Administration et al., (No. 17-70162).

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , , , , | Leave a comment

Maine: Lawmakers Override Governor’s Veto, Amend Voter-Initiated Adult Use Measure

Maine lawmakers have voted overwhelmingly to override Republican Gov. Paul LePage’s veto of LD 1719; the enactment of the legislation establishes a framework for the retail sale of marijuana to adults, but also amends numerous provisions of the 2016 voter-approved measure — including those specific to home grow limits and taxation.

Specifically, LD 1719 limits the number of mature plants an adult may cultivate at home from six to three. The measure also repeals language permitting the establishment of social-use facilities, and increases the excise tax rates on the sale of wholesale marijuana products. It also makes it easier for communities that wish to ban adult use operations to do so.

However, the measure also permits state regulators for the first time to move forward with the establishment of rules permitting for the commercial production and retail sale of cannabis to adults. Legislators anticipate that it will be until 2019 before these facilities are operational.

Governor LePage, an ardent opponent of the 2016 initiative, vetoed LD 1719 last week, opining that he, “in good conscience cannot support a law that, on its face, violates federal law.” The Governor had previously vetoed a less conservative implementation bill last November. That bill did not amend home cultivation limits and did not outright ban social use establishments.

NORML Deputy Director Paul Armentano expressed mixed emotions about the law’s passage. “On the one hand, we are grateful that regulators can now — after months of undue delay — finally begin moving forward with the process of licensing adult use marijuana sales and regulating this retail market. On the other hand, it is unfortunate that lawmakers felt it necessary to amend and repeal other important provisions of Question 1, the Marijuana Legalization Act, in what ultimately was futile effort to curry favor with the Governor,” he said. “At the end of the day, this measure is far from consistent with the language that the majority of voters approved at the ballot box.”

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , , , , | Leave a comment

Thailand’s Legendary Marijuana

Thailand's Legendary Marijuana

Recently, there have been signs that the Thai government is softening its stance on marijuana.

By Peter Maguire

April 30, 2018

For decades, Thailand was one of America’s most resolute allies in the war on drugs. After zero tolerance policies left the Kingdom with the highest rate of incarceration in Asia and a methamphetamine (ya ba) epidemic that not even the most draconian measures could stop, Justice Minister Paiboon Koomchaya shocked the nation in 2016 when he conceded that “the world has lost the war on drugs.” Not only did he suggest legalizing methamphetamine, Koomchaya urged his countrymen to view the drug epidemic through the lens of public health, rather than law enforcement. Today, many hope that this new laissez-faire approach will lead to the legalization of the legendary marijuana that was once among the Kingdom’s most famous and valuable exports.

After the United States built military bases in Thailand during the 1960s and stationed tens of thousands of U.S. soldiers there, the marijuana industry exploded and cheap, powerful pot became as readily available as beer.

“They tie together. Put the stick. Make it nice. Sell for GI easy. One, two, or five for one dollar,” recalled a Thai smuggler who got his start selling pot to U.S. soldiers. “Whatever place GI go, it started whenever they need.” 

“With an eighty-cent bottle of gin purchased at the PX,” one Vietnam veteran remembers, “you could trade for a pack of twenty Thai sticks.”

Thai Sticks c. 1974. Photo Michael Ferguson

The first Thai marijuana to reach the United States came in the 1960s via the Army Post Office. The difference between Thai marijuana and most Vietnamese and Cambodian cannabis, was the difference between bathtub corn whiskey and single malt scotch. In 1967, one amazed DEA agent to called it “the Cuban cigar of the marijuana world.”

“Who can forget the first strange-looking Thai Sticks a decade ago! Dense, seedless, stronger than a bull elephant. Years before sophisticated sinsemilla techniques were incorporated into the crop management of U.S. growers,” wrote High Times magazine, the journal of record for pot connoisseurs, “the Thais were, without effort, turning out a superior product.” What sold for $3 per kilo at the farm in Isan, easily fetched $4,000 a kilo in any city in the United States in the early 1970s.

The foreign demand for marijuana produced a boom in Thailand’s poorest region during the 1970s and 80s. North of Udorn on the banks of the Mekong sits Isan, a plateau as large as many American states (62,000 square miles) that floods during monsoon season and is arid and dusty during the dry season. Although rice fields are hard to irrigate and do not yield much, marijuana thrives thanks to the Mekong River, whose tributaries replenish the region with rich, silty soil. Farmers in Northeast Thailand take the same care with their cannabis plants that French vintners take with their grapevines.

“They know how to grow so nice, I mean how to take care of the flower, how to take out the male plant,” said one retired Thai marijuana broker. After they harvested and dried the cannabis sativa flowers (buds), the farmers and their families neatly and uniformly tied them to small bamboo sticks and secured them with threads of hemp fiber. 

What made the criminalization of marijuana particularly difficult, not just in Thailand, but certain parts of Southeast Asia, was that it was considered little more than a medicinal or cooking herb with little or no local legal or moral stigma attached. The plant had grown in Thailand, Laos, Cambodia, and Vietnam for centuries and various preparations were used to treat:  migraine headaches, cholera, malaria, dysentery, asthma, digestion, parasites, and post-childbirth pain.

“Almost every corner, every house, they have it in the yard growing. The older people, they will like it. The working heavy guy, he will like it,” said one retired Thai grower, “but they use for medicine also, when you really feel fever. So if you have nothing there, you can get like one branch, and ground it up.” 

Under Thailand’s 1934 Marijuana Act, penalties for any amount of the plant could not exceed one year in prison. When criticized by American officials for tolerating cannabis, Thailand leaders were quick to remind them that drug abuse was not part of their culture.

“The United States has been able to send men to the Moon. It has built sophisticated weapons for its own defense. Why can’t it do anything effective about narcotics getting to its shores,” Prime Minister Kriangsak Chamanan said in 1977. He reminded the Americans of the rules of capitalism, “Where there are markets, there is bound to be trade, either legal or illegal.” This point was echoed by Alfred McCoy, in his magisterial study, The Politics of Heroin in Southeast Asia, “Driven by myopic moralism, U.S. policy ignores the fundamental dynamics of the drug trade. Over the past two centuries, narcotics have become the major global commodities that operate on fluid laws of supply and demand not susceptible to simple repression.” 

A load of Thai Sticks Intercepted by Thai police. Photo Bangkok Post.

During the 1980s, the U.S. government was able to convince and coerce Thailand to partner with them in a war against marijuana. In 1988 alone, the U.S. Coast Guard intercepted eight “motherships” that carried 463,000 pounds of Southeast Asian marijuana bound for American shores. However, in the end, the “victory” was Pyrrhic because Thai drug users replaced cannabis with methamphetamine that is today responsible for 90 percent of that nation’s drug arrests.

Recently, there have been signs that the Thai government is softening its stance on marijuana. A research team at Rangsit University received permission from Thailand’s Narcotics Control Board and made a cannabis extract spray for cancer patients. In April, Dr. Arthit Uraitat, the rector of Rangsit University, called on Thailand’s military leaders to legalize medical marijuana.

“Be brave. Let us use medical marijuana legally regardless of the method,” he said in a press conference, “Those who have cancer, they cannot wait. They need the help now, so I think we need to take every shortcut possible.”

Last week, a private company called the Thai Cannabis Corporation announced the start of a five-year cannabis project that will cultivate 5,000 hectares (12,355 acres) of the plant in the next five years. The Royal Project Foundation will oversee this effort and Maejo University will provide research support. Thai Cannabis Corporation’s objective is to establish a low-cost model to grow, harvest, and process cannabis plants into oils and extracts. Initially, they will focus on breeding high CBD (cannabidiol) cannabis strains that contain minimal amounts of THC (tetrahydrocannabinol) in order to comply with the laws of Thailand. “The mission of the Royal Project Foundation is to research and develop appropriate technology to sustainably improve the quality of life for Thailand’s highland communities. I quite agree with the Thai Cannabis Project,” said the director of the Royal Project Foundation Dr. Vijit Thanormthin. 

The Royal Project Foundation was established and funded by King Bhumibol Adulyadej in 1969. An early advocate of sustainable farming, the king sought to improve the quality of life of Thailand’s hill tribes by replacing opium with other crops and also revitalizing Thailand’s forests and safeguarding their water resources for future generations.  Cannabis fits very neatly into the Royal Project Foundation’s mandate given that Thailand’s hill tribes were once the world’s premier marijuana growers. The nation is already exporting packaged food, beverages, essential oils, pharmaceuticals, medical devices, and cosmetics. Why not marijuana?

While the Thai Cannabis Corporation hopes to include the marijuana that Thailand was once world famous for in their product line, they will only go as rapidly as the law and Thai government will allow. “The mission of the Thai Cannabis Corporation,” said CEO Timothy Luton, “is to provide an excellent return to shareholders by partnering with Thailand’s farmers and scientific researchers to make, at high volumes and affordable prices, cannabis products that are above reproach.”

Thailand’s slow shift towards marijuana legalization stands in stark contrast to America’s anarchic “Green Rush,” the greatest exhibition of human greed since gold was discovered in California in 1849. Unlike Vietnam, Cambodia, and Laos, a foreign army has never occupied Thailand and they have staved off foreign invaders for centuries. Generations of Western businessmen have been baffled by their unique and refined Buddhist sensibility that often seems to value mental equilibrium and social grace as much as profit. 

However, behind the smile and behind the wai are some of the toughest people on earth. Rapacious western marijuana speculators looking to get rich quick would be wise to heed the words of Townsend Harris, the American envoy to Siam (Thailand), who wrote in 1856: “It is an old saying here [in Bangkok] that those who come here for business should bring one ship loaded with patience, another loaded with presents, and a third ship for carrying away the cargo.”

Peter Maguire is the author of Thai Stick:  Surfers, Scammers, and the Untold Story of the Marijuana Trade, Facing Death in Cambodia, and Law and War: International Law and American History. He has taught history at Columbia University, Bard College, and the University of North Carolina Wilmington.

CONTINUE READING…

https://thaicannabiscorporation.com/

Categories: US Hemp Co Museum | Leave a comment

NORML PAC Endorses Beto O’Rourke for Senate


The National Organization for the Reform of Marijuana Laws Political Action Committee (NORML PAC) has announced its endorsement of Beto O’Rourke for Senate in his race to unseat Senator Ted Cruz in Texas.

“Beto has been a true champion for abolishing our disastrous prohibition on marijuana since the very beginning of his political career as a city council member in El Paso. We were pleased to support him in his previous campaign for the House of Representatives and excited to endorse him again in his race for the US Senate,” said NORML PAC Executive Director Erik Altieri, “As Senator, O’Rourke will be an outspoken and indispensable ally in reforming our federal laws relating to marijuana and fight to finally end our failed prohibitionist policies that are currently tearing apart families, oppressing communities of color, squandering countless tax dollars, and filling the coffers of criminal cartels. The time has come for our nation to move towards the sensible policy of regulation and legalization, sending Beto to the Senate would bring us yet another step closer to that goal.”

“We must end the federal prohibition on marijuana in this country,” said O’Rourke. “Texas should be leading the way by encouraging comprehensive reforms in drug control policies that have had a devastating effect on communities of color.”

Recent polling on the Texas Senate race showed O’Rourke running neck and neck with Ted Cruz with Cruz claiming the support of 47% of state voters and 44% supporting O’Rourke.

According to a 2017 poll by the University of Texas, 83 percent of Texans support legalizing marijuana for some use and 53 percent would go beyond legal medical marijuana to allow possession for any use.

According to an April 2018 poll from Quinnipiac University, 63% of all Americans support the legalization of marijuana nationwide.

“Texas ranks as one of the states with the highest arrests rates for simple possession of marijuana, at an estimated cost of 1.5 billion in taxpayer money annually,” said Jax Finkel, Executive Director of Texas NORML. “Beto O’Rourke understands that our federal prohibition is a failed policy and it is past time for Congress to end it and allow states like Texas the freedom to pursue new, sensible alternatives.”

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , | Leave a comment

Study: Frequent Cannabis Use Unrelated To Brain Morphology

Marijuana researchThe frequent use of cannabis is not associated with changes in brain structure, according to data published online ahead of print in the journal Addiction.

An international team of scientists from Australia, the United Kingdom, and the United States assessed the relationship between habitual cannabis exposure and grey matter volumes in seven regions of the brain – including the thalamus, hippocampus, amygdala, and the nucleus accumbens – in two large population-based twin samples.

Researchers reported, “[N]ormal variation in cannabis use is statistically unrelated to individual differences in brain morphology as measured by subcortical volume.”

By contrast, the repeated use of nicotine was positively associated with significantly smaller thalamus volumes in middle-aged males.

Authors concluded: “This is the largest exploratory analysis integrating brain imaging with self-report cannabis and comorbid substance use data. After correcting for multiple testing, there was no effect of cannabis use on the volume at any subcortical region of interest in young adults or middle-aged males. … In the context of expanding medicalization and decriminalization and the concerns surrounding the consequences of increased cannabis availability, our findings suggest that normal variation in cannabis use is statistically unrelated to brain morphology as measured by subcortical volumes in non-clinical samples.”

The findings are consistent with those of prior brain imaging studies reporting that cannabis exposure appears to have little to no significant adverse impact upon brain morphology — particularly when compared to the dramatic effects associated with the alcohol exposure.

The study’s findings fail to replicate those of a well-publicized 2014 paper which alleged that even casual marijuana exposure may be linked to brain abnormalities, particularly in the amygdala.

Last week, a meta-analysis of 69 separate studies reported that cannabis exposure in adolescents and young adults is not associated with any significant, residual detrimental effects on cognitive performance. The results from a pair of recently published longitudinal twin studies similarly report that cannabis use is not independently associated with any residual change in intelligence quotient or executive function.

An abstract of the study, “Testing associations between cannabis use and subcortical volumes in two large population-based samples,” appears online here.

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , | Leave a comment

(KY) Hemp shows potential for treating ovarian cancer

Researchers demonstrate hemp’s ability to slow cancer growth and uncover mechanism for its cancer-fighting ability

Experimental Biology 2018

IMAGE

Results from some of the first studies to examine hemp’s ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn’t have any psychoactive properties or cause addiction.

Sara Biela and Chase Turner, graduate students in the lab of Wasana Sumanasekera at Sullivan University College of Pharmacy in Kentucky, will present new findings tied to hemp’s anti-cancer properties at the American Society for Biochemistry and Molecular Biology annual meeting during the 2018 Experimental Biology meeting to be held April 21-25 in San Diego.

“Hemp, like marijuana, contains therapeutically valuable components such as cannabidiol, cannabinol, and tetrahydrocannabinol,” explained Biela. “However, unlike marijuana, hemp’s therapeutic ability has not been studied in detail.”

Two new studies examined the therapeutic potential of an extract known as KY-hemp, which is produced from hemp grown in Kentucky. The plant strain, growing conditions and processing techniques were all optimized to produce an extract containing substances with potential therapeutic benefit and to eliminate any residue that could contaminate the product.

In one study, the researchers found that adding various doses of KY-hemp extract to cultured ovarian cells led to significant dose-dependent slowing of cell migration. This finding indicated that the extract might be useful for stopping or slowing down metastasis — the spreading of cancer to other parts of the body.

In a second study, the researchers explored the biology of KY-hemp’s protective effects against ovarian cancer, which they had observed in previous studies. Experiments with cultured ovarian cancer cells showed that KY-hemp slowed the secretion of the interleukin IL-1 beta. Interleukins produce inflammation that can be damaging and has been linked to cancer progression. The hemp-induced slowing of IL-1 β secretion represents a possible biological mechanism responsible for KY-hemp’s anti-cancer effects.

“Our findings from this research as well as prior research show that KY hemp slows ovarian cancer comparable to or even better than the current ovarian cancer drug Cisplatin,” said Turner. “Since Cisplatin exhibits high toxicity, we anticipate that hemp would carry less side effects. However, that needed to be tested in the future.”

The researchers plan to test the extract in mice after they complete additional studies in cultured cancer cells to learn more about how it leads to cancer cell death.

CONTINUE READING…

###


Categories: US Hemp Co Museum | Leave a comment